AKT1, SRC, and VEGFA were found to have the binding energy of < −5 kcal/mol with all key targets of diabetic retinopathy (Table 4), suggesting the good binding energy towards the key targets of diabetic retinopathy. Here, AKT1 is linked to diabetic retinopathy.